Experience with a failed postmarketing drug surveillance program

J Clin Pharmacol. 1984 Jan;24(1):3-5. doi: 10.1002/j.1552-4604.1984.tb01807.x.
No abstract available

MeSH terms

  • Drug Industry
  • Drug-Related Side Effects and Adverse Reactions*
  • Evaluation Studies as Topic*
  • Humans
  • Product Surveillance, Postmarketing*
  • United States